Evidence map›Paper›PMID 40358755›Full record

ReviewInnere Medizin (Heidelberg, Germany)2025

[Transition in gastroenterology and hepatology].

Britta Siegmund, Philip Bufler

Abstract readEnglish AbstractReview
PubMed Publisher
In one paragraph

Review in Innere Medizin (Heidelberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Britta SiegmundMedizinische Klinik für Gastroenterologie, Infektiologie und Rheumatologie, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Hindenburgdamm 30, 12203, Berlin, Deutschland. britta.siegmund@charite.de.
Philip BuflerKlinik für Pädiatrie mit Schwerpunkt Gastroenterologie, Nephrologie und Stoffwechselmedizin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic diseases of the gastrointestinal tract or the liver manifest themselves in a significant number of patients as early as childhood or adolescence. The majority of these diseases require complex drug therapy and continuous care. This makes the transition to adult medicine all the more critical, as it is a challenging phase of life per se. This article will present examples from various gastroenterology and hepatology centers. Subsequently, position papers and guidelines from national and international specialist societies will be discussed. Finally, the Berlin Transition Program (Berliner TransitionsProgramm, BTP) will be presented as a possible model for gastroenterology.

Indexed as

GastroenterologyGastrointestinal DiseasesLiver DiseasesTransition to Adult CareAdolescentAdultChildChronic DiseaseGermanyHumansAdult careChronic liver diseasesInflammatory bowel diseasesPediatricsTransition/guidelines

Identifiers

PMID40358755

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.